- $103.34bn
- $139.69bn
- $77.79bn
- 74
- 56
- 17
- 47
2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84,818 | 58,656 | 62,286 | 66,608 | 77,794 |
Cost of Revenue | |||||
Gross Profit | 12,725 | -5,187 | 3,049 | 3,530 | 7,724 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 86,793 | 71,423 | 65,156 | 70,127 | 78,567 |
Operating Profit | -1,975 | -12,767 | -2,870 | -3,519 | -773 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2,259 | -14,476 | -5,033 | -5,022 | -2,005 |
Provision for Income Taxes | |||||
Net Income After Taxes | -636 | -13,116 | -4,290 | -5,053 | -2,242 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -636 | -11,873 | -4,202 | -4,935 | -2,222 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -636 | -11,873 | -4,202 | -4,935 | -2,222 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.32 | -15.8 | -7.46 | -6.26 | -1.98 |
Dividends per Share |